Bio Essence Corporation (OTCQB: BIOE) to Acquire MediFlow AI Platform, Strengthening Its Human Health and Wellness Portfolio

About this update from Bio Essence Corp.

[{"type":"text","content":"Global AI in Fitness and Wellness Market Size was valued at USD 10.68 Billion in 2025 and is predicted to reach USD 57.80 Billion by the year 2035 at a 19.3% CAGR during the forecast period for 2026 to 2035.","length":207,"tagName":"p"},{"type":"text","content":"IRVINE, CA / ACCESS Newswire / April 27, 2026 / Bio Essence Corporation (OTCQB:BIOE) ("Bio Essence" or the "Company"), a specialized health and wellness provider, today announced that it has entered into a definitive Asset Purchase Agreement to acquire the MediFlow AI platform from Zhituo Software Co., Limited.","length":332,"tagName":"p"},{"type":"text","content":"MediFlow AI is an advanced technology platform built to provide data-driven wellness and lifestyle solutions for human use. By integrating this platform, Bio Essence enhances its ability to deliver personalized wellness services, leveraging proprietary algorithms to help users manage their health more effectively.","length":315,"tagName":"p"},{"type":"text","content":"The acquisition secures Bio Essence's ownership of a sophisticated technical framework designed exclusively for human wellness management. The Purchased Assets include all software source and object code, system architecture, databases, proprietary algorithms, and technical frameworks.","length":290,"tagName":"p"},{"type":"text","content":"Elevating Personal Wellness Through AI","length":38,"tagName":"p"},{"type":"text","content":"Key Transaction Details:","length":24,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Strategic Acquisition: Bio Essence will acquire all right, title, and interest in the MediFlow AI platform to expand its core health and wellness offerings.","length":156,"tagName":"p"}]},{"val":[{"type":"text","content":"Consideration: The aggregate purchase price for the assets is USD $3,500,000, which will be paid in shares of restricted common stock of Bio Essence Corporation.","length":161,"tagName":"p"}]},{"val":[{"type":"text","content":"Timeline: The transaction is expected to close within 45 days of the signing, subject to customary closing conditions and approval by the Bio Essence Board of Directors.","length":169,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":486,"olType":false},{"type":"text","content":"Management Commentary","length":21,"tagName":"p"},{"type"...

More updates from Bio Essence Corp.